Mold-Tek Packaging

Mold-Tek Packaging delivered robust quarterly results with revenue growth of 22% and EBITDA margin improving to 19.7% from 18% in the previous year. Net profit increased by 35% and EBITDA per kg grew by 29%. The paint segment drove significant growth, primarily supported by Aditya Birla Grasim (ABG), while the pharma segment achieved breakeven and grew 11% over Q4. Food & FMCG segment recorded 16% growth despite early monsoons affecting ice cream and yogurt consumption. The company processed 11,400 tons across segments: paints (5,600 tons), lubricants (2,400 tons), Food & FMCG (3,200 tons), and pharma (190 tons). Per kg sales revenue increased from INR198 to INR211. Management targets INR35 crores revenue for pharma segment in the current financial year, up from INR8-9 crores last year. The company is expanding capacity with Panipat thin wall food production starting in August and additional pharma capacity investments of INR80-90 crores planned. Multiple pharma companies including Laurus Labs and Pulse have approved facilities and started commercial orders. The company expects overall volume of 43,000-45,000 tons for the full year with 12-15% value growth.

Mold-Tek Packaging reported Q1 net profit of 224 million rupees, representing a significant increase from 165 million rupees in the same period last year. The company's EBITDA rose to 468 million rupees compared to 357 million rupees year-over-year. EBITDA margin improved to 19.45% from 18.16% in the previous year, indicating enhanced operational efficiency and profitability.

Mold-Tek Packaging Limited has scheduled a conference call on July 28, 2025, at 4:00 PM IST to discuss the company's Q1FY26 financial results with investors. The call will be hosted by J Lakshmana Rao, Chairman and Managing Director, in collaboration with Emkay Global Financial Services. The company has provided multiple dial-in numbers for domestic and international participants, with pre-registration available to avoid wait times.